{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:16:39Z","timestamp":1793067399889,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["AZV NV18-05-00162"],"award-info":[{"award-number":["AZV NV18-05-00162"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV19-05-00332"],"award-info":[{"award-number":["NV19-05-00332"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["GAUK 460218"],"award-info":[{"award-number":["GAUK 460218"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>X-linked inhibitor of apoptosis (XIAP) is the most potent human inhibitor of apoptosis, and is also involved in NOD2-dependent NF\u03baB and MAPK signalling cascade activation. The absence or defective function of XIAP leads to the development of a rare and severe primary immunodeficiency known as X-linked lymphoproliferative syndrome type 2 (XLP-2), which is characterized by a triad of clinical manifestations, including a high incidence of haemophagocytic lymphohistiocytosis (HLH), lymphoproliferation and inflammatory bowel disease (IBD), usually with very early onset. Here, we present a novel <jats:italic>XIAP<\/jats:italic> mutation identified in a patient with atypical adult-onset IBD complicated by relapsing HLH, splenomegaly and sarcoid-like disease. The c.266delA mutation in the <jats:italic>XIAP<\/jats:italic> gene creates a premature stop codon, and causes a severe reduction in XIAP protein expression. The mutation is also associated with impaired spontaneous and staurosporine- and PMA-induced apoptosis accompanied by significantly increased expression of pro-apoptotic genes. We also confirmed the negative impact of this particular <jats:italic>XIAP<\/jats:italic> mutation on NOD2-dependent NF\u03baB and MAPK activation, while NOD2-independent activation was found to be unaffected. Moreover, we assume that the mutation has an impact on the overproduction of IL-12 and IFN\u03b3, the shift towards the Th1 immune response and increased numbers of central memory and effector memory CD4+ and CD8+ T cells. All these changes contribute to immune dysregulation and the clinical manifestation of XLP-2.<\/jats:p>","DOI":"10.1038\/s41419-020-2652-4","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T10:05:56Z","timestamp":1591610756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Novel XIAP mutation causing enhanced spontaneous apoptosis and disturbed NOD2 signalling in a patient with atypical adult-onset Crohn\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Zuzana","family":"Parackova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Milota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Vrabcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Smetanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Svaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-7053","authenticated-orcid":false,"given":"Tomas","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Kanderova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sediva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"2652_CR1","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1128\/MCB.24.16.7003-7014.2004","volume":"24","author":"JC Wilkinson","year":"2004","unstructured":"Wilkinson, J. C., Cepero, E., Boise, L. H. & Duckett, C. S. Upstream regulatory role for XIAP in receptor-mediated apoptosis. Mol. Cell. Biol. 24, 7003\u20137014 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"2652_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/40901","volume":"388","author":"QL Deveraux","year":"1997","unstructured":"Deveraux, Q. L., Takahashi, R., Salvesen, G. S. & Reed, J. C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388, 300\u2013304 (1997).","journal-title":"Nature"},{"key":"2652_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ceb.2012.11.004","volume":"24","author":"NS Kenneth","year":"2012","unstructured":"Kenneth, N. S. & Duckett, C. S. IAP proteins: regulators of cell migration and development. Curr. Opin. Cell Biol. 24, 871\u2013875 (2012).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2652_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/cdd.2009.81","volume":"17","author":"S Galb\u00e1n","year":"2010","unstructured":"Galb\u00e1n, S. & Duckett, C. S. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 17, 54\u201360 (2010).","journal-title":"Cell Death Differ."},{"key":"2652_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.immuni.2009.04.011","volume":"30","author":"MJM Bertrand","year":"2009","unstructured":"Bertrand, M. J. M. et al. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30, 789\u2013801 (2009).","journal-title":"Immunity"},{"key":"2652_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/35085597","volume":"412","author":"C Wang","year":"2001","unstructured":"Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346\u2013351 (2001).","journal-title":"Nature"},{"key":"2652_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/sj.emboj.7601962","volume":"27","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa, M. et al. A critical role of RICK\/RIP2 polyubiquitination in Nod-induced NF-\u03baB activation. EMBO J. 27, 373\u2013383 (2008).","journal-title":"EMBO J."},{"key":"2652_CR8","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.0907131106","volume":"106","author":"A Krieg","year":"2009","unstructured":"Krieg, A. et al. XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl Acad. Sci. USA 106, 14524\u201314529 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2652_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.molcel.2012.04.014","volume":"46","author":"RB Damgaard","year":"2012","unstructured":"Damgaard, R. B. et al. The ubiquitin ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity. Mol. Cell 46, 746\u2013758 (2012).","journal-title":"Mol. Cell"},{"key":"2652_CR10","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/emmm.201303090","volume":"5","author":"RB Damgaard","year":"2013","unstructured":"Damgaard, R. B. et al. Disease\u2010causing mutations in the XIAP BIR 2 domain impair NOD 2\u2010dependent immune signalling. EMBO Mol. Med. 5, 1278\u20131295 (2013).","journal-title":"EMBO Mol. Med."},{"key":"2652_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-genom-082908-150013","volume":"10","author":"J Van Limbergen","year":"2009","unstructured":"Van Limbergen, J., Wilson, D. C. & Satsangi, J. The genetics of Crohn\u2032s disease. Annu. Rev. Genomics Hum. Genet. 10, 89\u2013116 (2009).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"2652_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/gutjnl-2013-306520","volume":"64","author":"Y Zeissig","year":"2015","unstructured":"Zeissig, Y. et al. XIAP variants in male Crohn\u2032s disease. Gut 64, 66\u201376 (2015).","journal-title":"Gut"},{"key":"2652_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semcdb.2015.01.015","volume":"39","author":"S Latour","year":"2015","unstructured":"Latour, S. & Aguilar, C. XIAP deficiency syndrome in humans. Semin. Cell Dev. Biol. 39, 115\u2013123 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"2652_CR14","doi-asserted-by":"publisher","unstructured":"Vallurupalli, M. & Berliner, N. Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis. Blood https:\/\/doi.org\/10.1182\/blood.2019002289 (2019).","DOI":"10.1182\/blood.2019002289"},{"key":"2652_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/bjh.12293","volume":"161","author":"GN Usmani","year":"2013","unstructured":"Usmani, G. N., Woda, B. A. & Newburger, P. E. Advances in understanding the pathogenesis of HLH. Br. J. Haematol. 161, 609\u2013622 (2013).","journal-title":"Br. J. Haematol."},{"key":"2652_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5223\/pghn.2019.22.1.41","volume":"22","author":"JO Shim","year":"2019","unstructured":"Shim, J. O. Recent advance in very early onset inflammatory bowel disease. Pediatr. Gastroenterol. Hepatol. Nutr. 22, 41 (2019).","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"2652_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clim.2013.07.004","volume":"149","author":"C Speckmann","year":"2013","unstructured":"Speckmann, C. et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin. Immunol. 149, 133\u2013141 (2013).","journal-title":"Clin. Immunol."},{"key":"2652_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/gim.2016.82","volume":"19","author":"OH Nielsen","year":"2017","unstructured":"Nielsen, O. H. & LaCasse, E. C. How genetic testing can lead to targeted management of XIAP deficiency\u2013related inflammatory bowel disease. Genet. Med. 19, 133\u2013143 (2017).","journal-title":"Genet. Med."},{"key":"2652_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00431-019-03512-7","volume":"179","author":"T Xu","year":"2020","unstructured":"Xu, T. et al. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic. Eur. J. Pediatr. 179, 327\u2013338 (2020).","journal-title":"Eur. J. Pediatr."},{"key":"2652_CR20","first-page":"A31","volume":"28","author":"T Y.","year":"2017","unstructured":"Y., T. et al. Gene therapy for X-linked inhibitor of apoptosis protein (XIAP) deficiency. Hum. Gene Ther. 28, A31\u2013A32 (2017).","journal-title":"Hum. Gene Ther."},{"key":"2652_CR21","doi-asserted-by":"publisher","first-page":"15630","DOI":"10.1074\/jbc.M110.176982","volume":"286","author":"J Liu","year":"2011","unstructured":"Liu, J. et al. X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton. J. Biol. Chem. 286, 15630\u201315640 (2011).","journal-title":"J. Biol. Chem."},{"key":"2652_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1053\/j.gastro.2018.03.069","volume":"155","author":"M Quaranta","year":"2018","unstructured":"Quaranta, M. et al. Consequences of identifying XIAP deficiency in an adult patient with inflammatory bowel disease. Gastroenterology 155, 231\u2013234 (2018).","journal-title":"Gastroenterology"},{"key":"2652_CR23","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","volume":"117","author":"JP Schmid","year":"2011","unstructured":"Schmid, J. P. et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency). Blood 117, 1522\u20131529 (2011).","journal-title":"Blood"},{"key":"2652_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10875-011-9638-z","volume":"32","author":"X Yang","year":"2012","unstructured":"Yang, X. et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J. Clin. Immunol. 32, 411\u2013420 (2012).","journal-title":"J. Clin. Immunol."},{"key":"2652_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","volume":"116","author":"RA Marsh","year":"2010","unstructured":"Marsh, R. A. et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood 116, 1079\u20131082 (2010).","journal-title":"Blood"},{"key":"2652_CR26","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1182\/blood-2010-03-275909","volume":"116","author":"AH Filipovich","year":"2010","unstructured":"Filipovich, A. H., Zhang, K., Snow, A. L. & Marsh, R. A. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood 116, 3398\u20133408 (2010).","journal-title":"Blood"},{"key":"2652_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","volume":"444","author":"S Rigaud","year":"2006","unstructured":"Rigaud, S. et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444, 110\u2013114 (2006).","journal-title":"Nature"},{"key":"2652_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1182\/blood-2013-01-479543","volume":"123","author":"IE Gentle","year":"2014","unstructured":"Gentle, I. E. et al. Inhibitors of apoptosis proteins (IAPs) are required for effective T-cell expansion\/survival during antiviral immunity in mice. Blood 123, 659\u2013668 (2014).","journal-title":"Blood"},{"key":"2652_CR29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ni.1782","volume":"10","author":"A Sabbah","year":"2009","unstructured":"Sabbah, A. et al. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10, 1073\u20131080 (2009).","journal-title":"Nat. Immunol."},{"key":"2652_CR30","doi-asserted-by":"publisher","first-page":"e92704","DOI":"10.1371\/journal.pone.0092704","volume":"9","author":"A Kapoor","year":"2014","unstructured":"Kapoor, A., Forman, M. & Arav-Boger, R. Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication. PLoS ONE 9, e92704 (2014).","journal-title":"PLoS ONE"},{"key":"2652_CR31","doi-asserted-by":"publisher","first-page":"e0185956","DOI":"10.1371\/journal.pone.0185956","volume":"12","author":"MA Ellison","year":"2017","unstructured":"Ellison, M. A., Gearheart, C. M., Porter, C. C. & Ambruso, D. R. IFN-\u03b3 alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils. PLoS ONE 12, e0185956 (2017).","journal-title":"PLoS ONE"},{"key":"2652_CR32","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3389\/fimmu.2017.01809","volume":"8","author":"Y Zhan","year":"2017","unstructured":"Zhan, Y., Carrington, E. M., Zhang, Y., Heinzel, S. & Lew, A. M. Life and death of activated T cells: how are they different from na\u00efve T cells? Front. Immunol. 8, 1809 (2017).","journal-title":"Front. Immunol."},{"key":"2652_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.coi.2007.05.005","volume":"19","author":"D Hildeman","year":"2007","unstructured":"Hildeman, D., Jorgensen, T., Kappler, J. & Marrack, P. Apoptosis and the homeostatic control of immune responses. Curr. Opin. Immunol. 19, 516\u2013521 (2007).","journal-title":"Curr. Opin. Immunol."},{"key":"2652_CR34","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.4049\/jimmunol.176.3.1553","volume":"176","author":"N Mikhalkevich","year":"2006","unstructured":"Mikhalkevich, N. et al. Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiation. J. Immunol. 176, 1553\u20131560 (2006).","journal-title":"J. Immunol."},{"key":"2652_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.immuni.2012.01.012","volume":"36","author":"JE Vince","year":"2012","unstructured":"Vince, J. E. et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36, 215\u2013227 (2012).","journal-title":"Immunity"},{"key":"2652_CR36","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","volume":"7","author":"M Yabal","year":"2014","unstructured":"Yabal, M. et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 7, 1796\u20131808 (2014).","journal-title":"Cell Rep."},{"key":"2652_CR37","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna, S. W. et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat. Genet. 46, 1140\u20131146 (2014).","journal-title":"Nat. Genet."},{"key":"2652_CR38","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ng.3066","volume":"46","author":"N Romberg","year":"2014","unstructured":"Romberg, N. et al. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat. Genet. 46, 1135\u20131139 (2014).","journal-title":"Nat. Genet."},{"key":"2652_CR39","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jaci.2014.04.031","volume":"134","author":"C Aguilar","year":"2014","unstructured":"Aguilar, C. et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis\u2013deficient male patients and female symptomatic carriers. J. Allergy Clin. Immunol. 134, 1131\u20131141.e9 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2652_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cei.12306","volume":"176","author":"S Ammann","year":"2014","unstructured":"Ammann, S. et al. A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency. Clin. Exp. Immunol. 176, 394\u2013400 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"2652_CR41","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.dld.2019.05.002","volume":"51","author":"T Engel","year":"2019","unstructured":"Engel, T. et al. Effectiveness and safety of Ustekinumab for Crohn\u2032s disease; systematic review and pooled analysis of real-world evidence. Dig. Liver Dis. 51, 1232\u20131240 (2019).","journal-title":"Dig. Liver Dis."},{"key":"2652_CR42","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"2652_CR43","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"2652_CR44","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"2652_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fgene.2012.00035","volume":"3","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, SnpSift. Front. Genet. 3, 35 (2012).","journal-title":"Front. Genet."},{"key":"2652_CR46","doi-asserted-by":"publisher","unstructured":"Parackova, Z. et al. Mutual alteration of NOD2-associated Blau syndrome and IFN\u03b3R1 deficiency. J. Clin. Immunol. https:\/\/doi.org\/10.1007\/s10875-019-00720-6 (2019).","DOI":"10.1007\/s10875-019-00720-6"},{"key":"2652_CR47","doi-asserted-by":"publisher","unstructured":"Kanderova, V. et al. Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in Caspase 8. Haematologica https:\/\/doi.org\/10.3324\/haematol.2018.201673 (2018).","DOI":"10.3324\/haematol.2018.201673"},{"key":"2652_CR48","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.humimm.2016.08.012","volume":"77","author":"J La\u0161\u0165ovi\u010dka","year":"2016","unstructured":"La\u0161\u0165ovi\u010dka, J., Rataj, M. & Bart\u016f\u0148kov\u00e1, J. Assessment of lymphocyte proliferation for diagnostic purpose: comparison of CFSE staining, Ki-67 expression and 3H-thymidine incorporation. Hum. Immunol. 77, 1215\u20131222 (2016).","journal-title":"Hum. Immunol."},{"key":"2652_CR49","doi-asserted-by":"publisher","unstructured":"Zentsova, I. et al. Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients. J. Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2019.06.005 (2019).","DOI":"10.1016\/j.jaut.2019.06.005"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2652-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2652-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2652-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:01:12Z","timestamp":1670252472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2652-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2652-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"23 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"430"}}